Bohui Innovation (300318.SZ): Jointly applied for freeze-dried type B influenza haemophilus influenzae combination vaccine obtained approval for clinical trials.

The Zhitong Financial APP news, Bohui Innovation (300318.SZ) announced that recently, the company's controlling subsidiary Bohui Biopharmaceutical Co., Ltd. (hereinafter referred to as "Langfang Bohui") and Beijing Baihui Biotechnology Co., Ltd. (hereinafter referred to as "Baihui Biotechnology") jointly applied for the freeze-dried type b influenza hemophilic bacillus combination vaccine, obtained the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration, and was approved to conduct clinical trials.